American Society of Addiction Medicine Handbook of Addiction Medicine

The American Society of Addiction Medicine Handbook of Addiction Medicine, Second Edition is a practical, evidence-based guide to caring for individuals with substance use disorder. Produced by the largest medical society dedicated to the improvement of addiction care, this new edition adopts non-stigmatizing language related to addiction and includes new material on LGBTQ care, vaping, and harm reduction. The second edition also carefully presents a compassionate, patient-centered approach to care.

To learn more about the American Society of Addiction Medicine, and its commitment to providing the best resources for addiction clinicians, please visit http: //www.asam.org.


Author: Darius Rastegar
Publisher: Oxford University Press, USA
Published: 08/01/2020
Pages: 464
Binding Type: Paperback
Weight: 1.10lbs
Size: 8.10h x 5.50w x 1.10d
ISBN13: 9780197506172
ISBN10: 0197506178
BISAC Categories:
- Medical | Neurology
- Medical | Psychiatry | General

About the Author

Darius A. Rastegar, MD, Associate Professor of Medicine Johns Hopkins School of Medicine, Michael I. Fingerhood, MD, Associate Professor of Medicine and Public Health, and Chief, Division of Addiction Medicine, Johns Hopkins University School of Medicine

Darius A. Rastegar, MD, Associate Professor of Medicine at Johns Hopkins School of Medicine, has over 20 years of clinical experience treating patients with substance use disorders. His primary clinical, teaching, and research interests have been in the treatment of opioid use disorders and alcohol withdrawal. Since 2009, Dr. Rastegar has served as an editor for the NIDA-funded newsletter Alcohol, Other Drugs and Health. He is also the founder and current Program Director for the Addiction Medicine Fellowship at Johns Hopkins, which began in 2018.

Michael I. Fingerhood, MD, is Associate Professor of Medicine and Public Health, and Chief of the Division of Addiction Medicine at Johns Hopkins Bayview Medical Center. His career's mission has been to promote and improve the provision of medical care to patients with substance use disorder, including the treatment of HIV and hepatitis C, with the development, maintenance and evaluation of innovative programs.